Frequently asked questions
What is the Risperdal lawsuit about?
Risperdal (risperidone), manufactured by Janssen Pharmaceuticals (a Johnson & Johnson subsidiary), was marketed for schizophrenia and bipolar disorder but was also widely prescribed off-label to children and adolescents. Mass tort lawsuits allege J&J concealed evidence that the drug causes gynecomastia—abnormal breast tissue growth in males—as well as hyperprolactinemia, weight gain, and other hormonal side effects. Thousands of plaintiffs have sued nationwide, and courts have imposed significant verdicts and settlements against J&J.
What is the statute of limitations for a Risperdal lawsuit in New York?
In New York, personal injury claims—including pharmaceutical injury claims like those involving Risperdal—are generally governed by a 3-year statute of limitations under CPLR §214. The clock typically starts running when the injury was discovered or reasonably should have been discovered, not necessarily when the drug was taken. For minors, the limitations period may be tolled until they turn 18, giving additional time to file. Because these timelines are fact-specific and can be complex, it is critical to consult a NY attorney promptly.
Who can file a Risperdal lawsuit in New York?
Any New York resident who took Risperdal and suffered qualifying injuries—most commonly gynecomastia (breast tissue development in males), hyperprolactinemia, tardive dyskinesia, or other documented hormonal side effects—may have grounds to file a claim. Parents or guardians may also file on behalf of minor children who were prescribed the drug. Claims are not limited to off-label prescriptions; patients who received Risperdal for any approved indication and suffered undisclosed side effects may also be eligible.
What damages can be recovered in a Risperdal lawsuit?
Damages in a successful Risperdal case may include medical expenses (including corrective surgery for gynecomastia), lost wages, pain and suffering, and emotional distress. New York does not cap compensatory damages in pharmaceutical injury cases. Punitive damages may also be available where plaintiffs can demonstrate that the manufacturer acted with reckless disregard for patient safety. No specific recovery amount can be guaranteed—outcomes depend on the individual facts, medical evidence, and other case-specific factors.